المؤلفون: Andrew M. Thompson (1621570), Patrick D. O’Connor (2072647), Vanessa Yardley (2179120), Louis Maes (191127), Delphine Launay (2553787), Stephanie Braillard (4019258), Eric Chatelain (115412), Baojie Wan (410986), Scott G. Franzblau (380600), Zhenkun Ma (798844), Christopher B. Cooper (1779883), William A. Denny (1621576)

مصطلحات موضوعية: Biochemistry, Medicine, Neuroscience, Pharmacology, Cancer, Infectious Diseases, Computational Biology, Chemical Sciences not elsewhere classified, Physical Sciences not elsewhere classified, Enhanced Solubility Antitubercular 7-, DNDI, development risks, novel amine, vivo efficacy, solubility improvements, side chain ether linkage, leishmaniasi, candidate profiles, urea functionality, Novel Linker Variants, latter groups, antileishmanial potency reduction, carbamate 66, antitrypanosomal activities

Relation: https://figshare.com/articles/journal_contribution/Novel_Linker_Variants_of_Antileishmanial_Antitubercular_7_Substituted_2_Nitroimidazooxazines_Offer_Enhanced_Solubility/13622397

الاتاحة: https://doi.org/10.1021/acsmedchemlett.0c00649.s001